Skip to main content
Aquarius Surgical Technologies Inc. logo

Aquarius Surgical Technologies Inc. — Investor Relations & Filings

Ticker · ASTI ISIN · CA03842P1009 CSE Manufacturing
Open in API
Filings indexed 217 across all filing types
Latest filing 2023-08-03 Regulatory Filings
Country CA Canada
Listing CSE ASTI

About Aquarius Surgical Technologies Inc.

https://aquariussurgical.com/

Aquarius Surgical Technologies Inc. specializes in the development, sale, distribution, and exploitation of technologies for surgical environments. The company is an exclusive provider and international distributor of innovative, minimally invasive medical laser systems and consumables. It focuses on delivering integrated laser-based solutions across multiple medical disciplines, complemented by comprehensive service, support, and training programs.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Regulatory Filings
2023-08-03 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-08-03 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2023-08-03 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONSOLIDATED INTERIM FINANCIAL STATEMENTS' for the three and nine month periods ended December 31, 2022 and 2021. It contains detailed unaudited financial statements including statements of financial position, loss, changes in deficiency, cash flows, and notes. The document references compliance with National Instrument 51-102 and includes management responsibility statements and board approvals. The length is substantial (15,000 characters), and it contains actual financial data and analysis for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-02-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the Interim CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. The document is a certification letter and does not contain actual financial data or the interim report itself. It explicitly states it is a certification under National Instrument 52-109 and clarifies the scope of the certification. The document length is 3079 characters, which is relatively short and consistent with a certification letter rather than a full interim report. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself.
2023-02-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2022. It is a certification letter rather than the interim report itself, and it explicitly states it is a certification under National Instrument 52-109. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS). The document length is short (3073 characters), and it does not contain actual financial data or substantive financial analysis, only the certification statement. Therefore, the correct classification is Regulatory Filings (RNS).
2023-02-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.